Diethylamine

Diethylamine

SCHEMBL6950381

CCNCC.c1ccc(Nc2nccc(-c3ccc(N4CCNCC4)nc3)n2)cc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZAP70 P43403 10/20 0.64
PRKCA P17252 3/20 0.64
PRKCD Q05655 3/20 0.64
PRKD3 O94806 2/20 0.64
PRKCG P05129 2/20 0.64
PRKCB P05771 2/20 0.64
LCK P06239 2/20 0.64
PRKCH P24723 2/20 0.64
PRKCI P41743 2/20 0.64
PRKCE Q02156 2/20 0.64
PRKCQ Q04759 2/20 0.64
PRKCZ Q05513 2/20 0.64
PRKD1 Q15139 2/20 0.64
EGFR P00533 2/20 0.64
IKBKB O14920 3/20 0.56
CHUK O15111 3/20 0.56
ACVR1 Q04771 2/20 0.53
MYLK4 Q86YV6 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
STK17A Q9UEE5 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952360 0.93 ZAP70 (0.68) ZAP70PRKCAPRKCDPRKD3PRKCG
Dimethylamine SCHEMBL7267011 0.92 ZAP70 (0.68) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6957436 0.86 ZAP70 (0.66) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6956894 0.84 ZAP70 (0.64) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6950380 0.83 ZAP70 (0.62) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6955195 0.83 ZAP70 (0.67) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6952805 0.83 ZAP70 (0.64) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6950848 0.83 ZAP70 (0.64) ZAP70PRKCAPRKCDPRKD3PRKCG
Dimethylamine SCHEMBL6950814 0.83 ZAP70 (0.64) ZAP70PRKCAPRKCDPRKD3PRKCG
SCHEMBL6950853 0.83 ZAP70 (0.66) ZAP70PRKCAPRKCDPRKD3PRKCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552029-B1 For therapy of rheumatoid arthritis, psoriasis, graft v. host disease, asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, complications following percutaneous transluminal coronary angioplasty, thrombosis CELLTECH R&D LIMITED (GB) 2003-04-22 US disclosed
EP-0934304-B1 2-PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION CELLTECH THERAPEUTICS LTD (GB) 2003-02-26 EP disclosed
US-6114333-A 2-Pyrimidineamine derivatives and processes for their preparation CELLTECH THERAPEUTICS LTD. (GB) 2000-09-05 US disclosed